Cost-Sharing Proposed Rule May Lead To Rebated Drug Price Disclosure

By John Wilkerson / November 18, 2019 at 5:49 PM
The health insurance transparency rule that HHS and other departments proposed Friday solicits input on whether to make plans disclose rebated- and list-prices for drugs. The Trump administration on Friday (Nov. 15) finished a rule on hospital price transparency and proposed a cost-sharing transparency rule for insurance that individuals buy and that employers provide . The insurer proposed rule, which was written by HHS, the Labor Department and the Internal Revenue Service, requests feedback on cost-sharing that could lead to...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.